Kromek Group plc (GB:KMK) has released an update.
Kromek Group plc, a developer of radiation and bio-detection technology solutions, has announced a delay in reporting its full year results, now expected in the second half of October 2024. The company has reported increased commercial momentum and anticipates positive EBITDA for the fiscal year 2024, surpassing market expectations. Improvements are credited to a favorable product mix, cost control, and operational efficiency, particularly in advanced imaging manufacturing.
For further insights into GB:KMK stock, check out TipRanks’ Stock Analysis page.
